Cargando…
VEGFA-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy
Retinal gene therapy using RNA interference (RNAi) to silence targeted genes requires both efficacy and safety. Short hairpin RNAs (shRNAs) are useful for RNAi, but high expression levels and activity from the co-delivered passenger strand may cause undesirable cellular responses. Ago2-dependent shR...
Autores principales: | Alsing, Sidsel, Doktor, Thomas Koed, Askou, Anne Louise, Jensen, Emilie Grarup, Ahmadov, Ulvi, Kristensen, Lasse Sommer, Andresen, Brage Storstein, Aagaard, Lars, Corydon, Thomas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933642/ https://www.ncbi.nlm.nih.gov/pubmed/35356684 http://dx.doi.org/10.1016/j.omtn.2022.02.019 |
Ejemplares similares
-
Targeted Knockout of the Vegfa Gene in the Retina by Subretinal Injection of RNP Complexes Containing Cas9 Protein and Modified sgRNAs
por: Holmgaard, Andreas Braae, et al.
Publicado: (2021) -
Animal Models of Choroidal Neovascularization: A Systematic Review
por: Fabian-Jessing, Bjørn K., et al.
Publicado: (2022) -
25 years of maturation: A systematic review of RNAi in the clinic
por: Corydon, Ida Juhl, et al.
Publicado: (2023) -
CUGBP1 and MBNL1 preferentially bind to 3′ UTRs and facilitate mRNA decay
por: Masuda, Akio, et al.
Publicado: (2012) -
Absence of an Intron Splicing Silencer in Porcine Smn1 Intron 7 Confers Immunity to the Exon Skipping Mutation in Human SMN2
por: Doktor, Thomas Koed, et al.
Publicado: (2014)